查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2129265

GLP-1支持營養產品市場預測（2034年）－全球產品類型、營養功能、劑型、成分、消費階段、通路、最終用戶和地區分析

GLP-1 Support Nutrition Products Market Forecasts to 2034 - Global Analysis By Product Type, Nutritional Function, Form, Ingredient, Consumer Stage, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球 GLP-1 支持營養產品市場預計到 2026 年將達到 14 億美元，並在預測期內以 8.5% 的複合年成長率成長，到 2034 年達到 27.9 億美元。

GLP-1支持營養產品是指專門為滿足GLP-1受體促效劑類藥物（用於體重管理和糖尿病治療）的營養需求和潛在副作用而設計的膳食補充劑和食品。這些產品旨在確保肌肉量維持、增強飽足感、促進消化健康並確保充足的微量營養素攝入，即使在食慾下降和體重減輕期間也能如此。其配方著重於優質蛋白質、膳食纖維、必需維生素、礦物質和電解質，以支持治療期間的整體健康。這些產品旨在輔助藥物治療，並支持永續的體重管理效果。

擴大GLP-1製劑的處方範圍

GLP-1受體促效劑在肥胖症和體重管理的處方量迅速成長，帶動了對營養產品的需求，以支持患者接受治療。人們對GLP-1治療期間全面營養支持需求的認知不斷提高，加速了市場發展。此外，人們對肌肉流失、胃腸道疾病和營養不良等潛在副作用的認知不斷增強，也擴大了目標市場。產品配方的持續創新正在提高營養支持的有效性。

缺乏臨床證據和缺乏標準化

關於GLP-1使用者最佳營養策略的臨床證據相對有限，且缺乏標準化指南，這可能導致消費者和醫療保健專業人員感到困惑。個體對GLP-1反應的差異十分複雜，需要採取個人化的方法。對醫療保健專業人員建議的需求以及產品品質可能存在的差異，都可能限制市場成長。

與醫療保健專業人員的建議合作

GLP-1支持營養產品在醫療專業人員的推薦和治療方案中日益普及，為市場帶來了巨大的成長機會。符合臨床標準並獲得醫療專業人員建議的產品不斷湧現，正在擴大目標市場。病患教育和營養諮詢計畫的普及，也讓更多消費者獲得協助，從而做出更合適的營養產品選擇。

與一般營養產品的競爭

市面上持續供應的普通膳食補充劑和蛋白質產品可能適用於GLP-1受體激動劑使用者，這對專門的GLP-1受體激動劑支撐產品構成了競爭威脅。人們普遍認為這些產品價格昂貴或沒有必要，這可能會阻礙其普及。此外，監管機構對健康益處聲明的審查風險以及醫療指南可能的變化，仍然是相關人員持續關注的問題。

新冠疫情的影響：

疫情初期，醫療服務取得受阻，導致人們在尋求體重管理建議方面有所延誤。疫情期間，人們對肥胖相關健康風險和慢性疾病的關注度提高，進一步擴大了對體重管理策略的認知。疫情後，對GLP-1製劑和輔助營養產品的需求增加，推動了市場顯著成長。

在預測期內，蛋白質產品細分市場預計將佔據最大佔有率。

鑑於蛋白質在GLP-1療法期間維持肌肉質量以及促進飽腹感以成功控制體重方面至關重要，預計在預測期內，蛋白質產品細分市場將佔據最大的市場佔有率。該細分市場受益於消費者對蛋白質在體重管理中作用的充分認知以及各種蛋白質產品的豐富選擇。蛋白質配方和便利包裝的不斷創新進一步鞏固了其作為最廣泛應用產品類型的領先地位。

預計在預測期內，粉末產品細分市場將呈現最高的複合年成長率。

在預測期內，粉狀產品預計將呈現最高的成長率，這主要得益於粉狀產品的多功能性和便利性。粉狀產品可以輕鬆混合到各種食品和飲料中，從而提高蛋白質和營養成分的含量。高品質粉末配方不斷改進，提升了口感和溶解度，進一步拓展了其應用範圍。消費者對靈活營養解決方案和個人化攝取的偏好日益成長，也加速了粉狀營養補充劑的普及。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其較高的GLP-1處方率、完善的醫療保健基礎設施以及美國眾多大型營養相關企業的存在。創新產品的上市以及不斷擴大的保險覆蓋範圍進一步鞏固了北美在該地區的市場領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要歸因於中國和印度等國家肥胖症和糖尿病盛行率的上升、醫療保健支出的增加以及人們對體重管理意識的提高。中產階級的壯大和飲食習慣的改變是該地區市場成長的主要驅動力。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球GLP-1支持營養產品市場：依產品類型分類

  • 蛋白質產品
  • 膳食纖維及消化健康產品
  • 微量營養素PC
  • 補水產品
  • 肌肉生長和恢復產品

第6章 全球GLP-1支持營養產品市場：依營養功能分類

  • 維持肌肉質量
  • 飽足感和食慾支持
  • 消化系統健康
  • 補水支持
  • 微量營養素支持
  • 能量補充

第7章 全球GLP-1支持營養產品市場：以劑型分類

  • 粉末
  • 膠囊和片劑
  • 即飲飲料
  • 酒吧/小吃店
  • 軟糖

第8章 全球GLP-1支持營養產品市場：依成分分類

  • 乳清蛋白
  • 植物來源蛋白
  • 膠原蛋白
  • 膳食纖維
  • 益生菌
  • 益生元

第9章 全球GLP-1支持營養產品市場：依消費階段分類

  • 治療前營養
  • 早期治療支持
  • 長期治療支持
  • 療程後的營養管理
  • 維持體重的營養產品
  • 典型的注重健康的消費者

第10章 全球GLP-1支援營養產品市場：依通路分類

  • 藥局/藥局
  • 超級市場和大賣場
  • 健康養生專賣店
  • 線上零售
  • 診所和醫療保健機構
  • 健身房/健身中心

第11章 全球GLP-1支援營養產品市場：依最終用戶分類

  • GLP-1藥物使用者
  • 出於體重管理目的的消費者
  • 肥胖管理診所
  • 醫療服務提供方
  • 其他最終用戶

第12章 全球GLP-1支持營養產品市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第13章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第14章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第15章：公司簡介

  • Nestle SA
  • Abbott Laboratories
  • Danone SA
  • PepsiCo, Inc.
  • General Mills, Inc.
  • Conagra Brands, Inc.
  • Simply Good Foods Co.
  • Herbalife Ltd.
  • USANA Health Sciences, Inc.
  • Thorne HealthTech, Inc.
  • Vital Proteins
  • Optimum Nutrition
  • The Bountiful Company
  • Kerry Group plc
  • DuPont de Nemours, Inc.
  • DSM-Firmenich AG
  • Unilever PLC
  • The Coca-Cola Company
Product Code: SMRC39422

According to Stratistics MRC, the Global GLP-1 Support Nutrition Products Market is accounted for $1.40 billion in 2026 and is expected to reach $2.79 billion by 2034 growing at a CAGR of 8.5% during the forecast period. GLP-1 support nutrition products refer to nutritional supplements and foods specifically designed to address the nutritional needs and potential side effects of GLP-1 receptor agonist medications used for weight management and diabetes treatment. These products are formulated to support muscle mass preservation, promote satiety, maintain digestive health, and ensure adequate micronutrient intake during periods of reduced appetite and weight loss. The formulations emphasize high-quality protein, fiber, essential vitamins, minerals, and electrolytes to support overall health during treatment. These products are designed to complement medical therapy and support sustainable weight management outcomes.

Market Dynamics:

Driver:

Expanding Prescription Base for GLP-1 Medications

The rapidly growing prescription rates for GLP-1 receptor agonist medications for obesity and weight management is driving demand for nutrition products that support patients during treatment. The increasing recognition of the need for comprehensive nutritional support during GLP-1 therapy is accelerating market development. The growing awareness of potential side effects including muscle loss, gastrointestinal issues, and nutritional deficiencies is expanding the addressable market. The continuous innovation in product formulations is improving the effectiveness of nutritional support.

Restraint:

Limited Clinical Evidence and Lack of Standardization

The relatively limited clinical evidence regarding optimal nutritional strategies for GLP-1 medication users and the lack of standardized guidelines can create confusion among consumers and healthcare providers. The complexity of addressing individual differences in response to GLP-1 medications requires personalized approaches. The need for healthcare provider recommendations and the potential for inconsistent product quality can limit market growth.

Opportunity:

Integration with Healthcare Provider Recommendations

The growing opportunity to integrate GLP-1 support nutrition products into healthcare provider recommendations and treatment plans presents significant growth potential for the market. The development of products that meet clinical standards and are endorsed by healthcare professionals is expanding the addressable market. The increasing availability of patient education and nutrition counseling programs is enabling broader consumer reach and appropriate product selection.

Threat:

Competition from General Nutrition Products

The continued availability of general nutrition supplements and protein products that may be suitable for GLP-1 users poses a competitive threat to specialized GLP-1 support products. The perception of specialized products as expensive or unnecessary can limit adoption. The risk of regulatory scrutiny regarding health claims and the potential for changing medical guidelines are ongoing concerns for industry stakeholders.

Covid-19 Impact:

The pandemic initially disrupted healthcare access and delayed weight management consultations. During the mid-pandemic period, the increased focus on obesity-related health risks and chronic disease management drove greater awareness of weight management interventions. Post-pandemic, the market has grown significantly with increased GLP-1 medication use and supporting nutrition products.

The protein products segment is expected to be the largest during the forecast period

The protein products segment is expected to account for the largest market share during the forecast period, due to the critical importance of protein for preserving muscle mass during GLP-1 treatment and supporting satiety for weight management success. This segment benefits from the established consumer understanding of protein's role in weight management and the availability of diverse protein product formats. The continuous innovation in protein formulations and convenient packaging further reinforces its dominance as the most widely adopted product type.

The powders segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the powders segment is predicted to witness the highest growth rate, driven by the versatility and convenience of powder formats that can be easily incorporated into various beverages and foods to boost protein and nutrient content. The development of high-quality powder formulations with improved taste and mixability is expanding their application range. The growing preference for flexible nutrition solutions and the ability to customize dosage are in turn accelerating the adoption of powder-based support products.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the high rates of GLP-1 medication prescriptions, established healthcare infrastructure, and presence of major nutrition companies in the United States. The availability of innovative products and supportive insurance coverage further reinforce the region's market leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to the growing prevalence of obesity and diabetes, increasing healthcare spending, and rising awareness of weight management in countries like China and India. The expanding middle class and changing dietary habits are key drivers of market growth in this region.

Key players in the market

Some of the key players in GLP-1 Support Nutrition Products Market include Nestle S.A., Abbott Laboratories, Danone S.A., PepsiCo, Inc., General Mills, Inc., Conagra Brands, Inc., Simply Good Foods Co., Herbalife Ltd., USANA Health Sciences, Inc., Thorne HealthTech, Inc., Vital Proteins, Optimum Nutrition, The Bountiful Company, Kerry Group plc, DuPont de Nemours, Inc., DSM-Firmenich AG, Unilever PLC and The Coca-Cola Company.

Key Developments:

In August 2026, Abbott Laboratories launched a comprehensive GLP-1 support nutrition line featuring high-protein shakes enriched with essential vitamins and minerals to promote adequate nutrient intake during weight management.

In July 2026, Nestle S.A. introduced GLP-1 support bars containing high levels of protein and fiber, complemented by electrolytes to support digestive health, hydration, and nutritional needs.

In June 2026, Danone S.A. unveiled specialized yogurt products designed for GLP-1 users, combining high protein, probiotics, and essential micronutrients to support nutritional adequacy and digestive wellness.

Product Types Covered:

  • Sensors
  • Probes and Analyzers
  • Software and Services

Types Covered:

  • Sensors
  • Probes and Analyzers
  • Software and Services

Service Types Covered:

  • Sensors
  • Probes and Analyzers
  • Software and Services

Technologies Covered:

  • Online Monitoring Systems
  • Offline Monitoring Systems
  • Remote Monitoring Systems

Applications Covered:

  • Surface Water Monitoring
  • Groundwater Monitoring
  • Drinking Water Monitoring
  • Wastewater Monitoring

End Users Covered:

  • Municipal Water Utilities
  • Industrial Facilities
  • Marine
  • Environmental Agencies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global GLP-1 Support Nutrition Products Market, By Product Type

  • 5.1 Protein Products
  • 5.2 Fiber & Digestive Health Products
  • 5.3 Micronutrient Products
  • 5.4 Hydration Products
  • 5.5 Muscle & Recovery Products

6 Global GLP-1 Support Nutrition Products Market, By Nutritional Function

  • 6.1 Muscle Mass Preservation
  • 6.2 Satiety & Appetite Support
  • 6.3 Digestive Health
  • 6.4 Hydration Support
  • 6.5 Micronutrient Support
  • 6.6 Energy Support

7 Global GLP-1 Support Nutrition Products Market, By Form

  • 7.1 Powders
  • 7.2 Capsules & Tablets
  • 7.3 Ready-to-Drink Beverages
  • 7.4 Bars & Snacks
  • 7.5 Gummies

8 Global GLP-1 Support Nutrition Products Market, By Ingredient

  • 8.1 Whey Protein
  • 8.2 Plant-Based Protein
  • 8.3 Collagen
  • 8.4 Fiber
  • 8.5 Probiotics
  • 8.6 Prebiotics

9 Global GLP-1 Support Nutrition Products Market, By Consumer Stage

  • 9.1 Pre-Treatment Nutrition
  • 9.2 Early Treatment Support
  • 9.3 Long-Term Treatment Support
  • 9.4 Post-Treatment Nutrition
  • 9.5 Weight Maintenance Nutrition
  • 9.6 General Wellness Consumers

10 Global GLP-1 Support Nutrition Products Market, By Distribution Channel

  • 10.1 Pharmacies & Drugstores
  • 10.2 Supermarkets & Hypermarkets
  • 10.3 Health & Wellness Stores
  • 10.4 Online Retail
  • 10.5 Clinics & Healthcare Providers
  • 10.6 Gyms & Fitness Centers

11 Global GLP-1 Support Nutrition Products Market, By End User

  • 11.1 GLP-1 Medication Users
  • 11.2 Weight Management Consumers
  • 11.3 Obesity Management Clinics
  • 11.4 Healthcare Providers
  • 11.5 Other End Users

12 Global GLP-1 Support Nutrition Products Market, By Geography

  • 12.1 North America
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Mexico
  • 12.2 Europe
    • 12.2.1 United Kingdom
    • 12.2.2 Germany
    • 12.2.3 France
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Netherlands
    • 12.2.7 Belgium
    • 12.2.8 Sweden
    • 12.2.9 Switzerland
    • 12.2.10 Poland
    • 12.2.11 Rest of Europe
  • 12.3 Asia Pacific
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 South Korea
    • 12.3.5 Australia
    • 12.3.6 Indonesia
    • 12.3.7 Thailand
    • 12.3.8 Malaysia
    • 12.3.9 Singapore
    • 12.3.10 Vietnam
    • 12.3.11 Rest of Asia Pacific
  • 12.4 South America
    • 12.4.1 Brazil
    • 12.4.2 Argentina
    • 12.4.3 Colombia
    • 12.4.4 Chile
    • 12.4.5 Peru
    • 12.4.6 Rest of South America
  • 12.5 Rest of the World (RoW)
    • 12.5.1 Middle East
      • 12.5.1.1 Saudi Arabia
      • 12.5.1.2 United Arab Emirates
      • 12.5.1.3 Qatar
      • 12.5.1.4 Israel
      • 12.5.1.5 Rest of Middle East
    • 12.5.2 Africa
      • 12.5.2.1 South Africa
      • 12.5.2.2 Egypt
      • 12.5.2.3 Morocco
      • 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

  • 13.1 Industry Value Network and Supply Chain Assessment
  • 13.2 White-Space and Opportunity Mapping
  • 13.3 Product Evolution and Market Life Cycle Analysis
  • 13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

  • 14.1 Mergers and Acquisitions
  • 14.2 Partnerships, Alliances, and Joint Ventures
  • 14.3 New Product Launches and Certifications
  • 14.4 Capacity Expansion and Investments
  • 14.5 Other Strategic Initiatives

15 Company Profiles

  • 15.1 Nestle S.A.
  • 15.2 Abbott Laboratories
  • 15.3 Danone S.A.
  • 15.4 PepsiCo, Inc.
  • 15.5 General Mills, Inc.
  • 15.6 Conagra Brands, Inc.
  • 15.7 Simply Good Foods Co.
  • 15.8 Herbalife Ltd.
  • 15.9 USANA Health Sciences, Inc.
  • 15.10 Thorne HealthTech, Inc.
  • 15.11 Vital Proteins
  • 15.12 Optimum Nutrition
  • 15.13 The Bountiful Company
  • 15.14 Kerry Group plc
  • 15.15 DuPont de Nemours, Inc.
  • 15.16 DSM-Firmenich AG
  • 15.17 Unilever PLC
  • 15.18 The Coca-Cola Company

List of Tables

  • Table 1 Global GLP-1 Support Nutrition Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global GLP-1 Support Nutrition Products Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global GLP-1 Support Nutrition Products Market Outlook, By Protein Products (2023-2034) ($MN)
  • Table 4 Global GLP-1 Support Nutrition Products Market Outlook, By Fiber & Digestive Health Products (2023-2034) ($MN)
  • Table 5 Global GLP-1 Support Nutrition Products Market Outlook, By Micronutrient Products (2023-2034) ($MN)
  • Table 6 Global GLP-1 Support Nutrition Products Market Outlook, By Hydration Products (2023-2034) ($MN)
  • Table 7 Global GLP-1 Support Nutrition Products Market Outlook, By Muscle & Recovery Products (2023-2034) ($MN)
  • Table 8 Global GLP-1 Support Nutrition Products Market Outlook, By Nutritional Function (2023-2034) ($MN)
  • Table 9 Global GLP-1 Support Nutrition Products Market Outlook, By Muscle Mass Preservation (2023-2034) ($MN)
  • Table 10 Global GLP-1 Support Nutrition Products Market Outlook, By Satiety & Appetite Support (2023-2034) ($MN)
  • Table 11 Global GLP-1 Support Nutrition Products Market Outlook, By Digestive Health (2023-2034) ($MN)
  • Table 12 Global GLP-1 Support Nutrition Products Market Outlook, By Hydration Support (2023-2034) ($MN)
  • Table 13 Global GLP-1 Support Nutrition Products Market Outlook, By Micronutrient Support (2023-2034) ($MN)
  • Table 14 Global GLP-1 Support Nutrition Products Market Outlook, By Energy Support (2023-2034) ($MN)
  • Table 15 Global GLP-1 Support Nutrition Products Market Outlook, By Form (2023-2034) ($MN)
  • Table 16 Global GLP-1 Support Nutrition Products Market Outlook, By Powders (2023-2034) ($MN)
  • Table 17 Global GLP-1 Support Nutrition Products Market Outlook, By Capsules & Tablets (2023-2034) ($MN)
  • Table 18 Global GLP-1 Support Nutrition Products Market Outlook, By Ready-to-Drink Beverages (2023-2034) ($MN)
  • Table 19 Global GLP-1 Support Nutrition Products Market Outlook, By Bars & Snacks (2023-2034) ($MN)
  • Table 20 Global GLP-1 Support Nutrition Products Market Outlook, By Gummies (2023-2034) ($MN)
  • Table 21 Global GLP-1 Support Nutrition Products Market Outlook, By Ingredient (2023-2034) ($MN)
  • Table 22 Global GLP-1 Support Nutrition Products Market Outlook, By Whey Protein (2023-2034) ($MN)
  • Table 23 Global GLP-1 Support Nutrition Products Market Outlook, By Plant-Based Protein (2023-2034) ($MN)
  • Table 24 Global GLP-1 Support Nutrition Products Market Outlook, By Collagen (2023-2034) ($MN)
  • Table 25 Global GLP-1 Support Nutrition Products Market Outlook, By Fiber (2023-2034) ($MN)
  • Table 26 Global GLP-1 Support Nutrition Products Market Outlook, By Probiotics (2023-2034) ($MN)
  • Table 27 Global GLP-1 Support Nutrition Products Market Outlook, By Prebiotics (2023-2034) ($MN)
  • Table 28 Global GLP-1 Support Nutrition Products Market Outlook, By Consumer Stage (2023-2034) ($MN)
  • Table 29 Global GLP-1 Support Nutrition Products Market Outlook, By Pre-Treatment Nutrition (2023-2034) ($MN)
  • Table 30 Global GLP-1 Support Nutrition Products Market Outlook, By Early Treatment Support (2023-2034) ($MN)
  • Table 31 Global GLP-1 Support Nutrition Products Market Outlook, By Long-Term Treatment Support (2023-2034) ($MN)
  • Table 32 Global GLP-1 Support Nutrition Products Market Outlook, By Post-Treatment Nutrition (2023-2034) ($MN)
  • Table 33 Global GLP-1 Support Nutrition Products Market Outlook, By Weight Maintenance Nutrition (2023-2034) ($MN)
  • Table 34 Global GLP-1 Support Nutrition Products Market Outlook, By General Wellness Consumers (2023-2034) ($MN)
  • Table 35 Global GLP-1 Support Nutrition Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 36 Global GLP-1 Support Nutrition Products Market Outlook, By Pharmacies & Drugstores (2023-2034) ($MN)
  • Table 37 Global GLP-1 Support Nutrition Products Market Outlook, By Supermarkets & Hypermarkets (2023-2034) ($MN)
  • Table 38 Global GLP-1 Support Nutrition Products Market Outlook, By Health & Wellness Stores (2023-2034) ($MN)
  • Table 39 Global GLP-1 Support Nutrition Products Market Outlook, By Online Retail (2023-2034) ($MN)
  • Table 40 Global GLP-1 Support Nutrition Products Market Outlook, By Clinics & Healthcare Providers (2023-2034) ($MN)
  • Table 41 Global GLP-1 Support Nutrition Products Market Outlook, By Gyms & Fitness Centers (2023-2034) ($MN)
  • Table 42 Global GLP-1 Support Nutrition Products Market Outlook, By End User (2023-2034) ($MN)
  • Table 43 Global GLP-1 Support Nutrition Products Market Outlook, By GLP-1 Medication Users (2023-2034) ($MN)
  • Table 44 Global GLP-1 Support Nutrition Products Market Outlook, By Weight Management Consumers (2023-2034) ($MN)
  • Table 45 Global GLP-1 Support Nutrition Products Market Outlook, By Obesity Management Clinics (2023-2034) ($MN)
  • Table 46 Global GLP-1 Support Nutrition Products Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 47 Global GLP-1 Support Nutrition Products Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.